Table 3.

Univariate analysis of potential prognostic factors

		OS		DFS		LC
Item	n	Mean survival time ± SE	Pvalue	Mean survival time ± SE	Pvalue	Mean survival time ± SE	Pvalue
Gender			0.013		0.018		0.015
Male	136	65 ± 5		61 ± 5		62 ± 5
Female	32	40 ± 7		38 ± 6		38 ± 6
Age (y)			0.858		0.868		0.779
<50	93	58 ± 6		55 ± 5		55 ± 5
≥50	75	60 ± 7		57 ± 6		58 ± 7
T- classification			0.795		0.647		0.720
1 + 2	96	68 ± 9		54 ± 5		55 ± 5
3 + 4	72	56 ± 5		62 ± 7		62 ± 7
rT- classification			0.057		0.232		0.186
1	65	65 ± 7		58 ± 6		60 ± 6
2	103	54 ± 5		53 ± 5		53 ± 5
Time to recurrence			0.38		0.293		0.334
<36 months	65	66 ± 7		64 ± 7		64 ± 7
≥36 months	103	55 ± 5		51 ± 5		52 ± 5
Treatment			0.707		0.749		0.715
3D-CRT	67	56 ± 7		56 ± 7		56 ± 7
IMRT	28	55 ± 7		55 ± 7		55 ± 7
Brachy	20	59 ± 9		47 ± 8		47 ± 8
Brachy + ER	53	60 ± 7		57 ± 7		58 ± 7
Dose (Gy)			0.304		0.221		0.246
<60	48	68 ± 9		66 ± 9		66 ± 9
≥60	120	56 ± 5		52 ± 5		53 ± 5